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A63-year-old woman was admitted with dyspnea and massive lower limb edema. Activehepatitis C virus (HCV) infection had been diagnosed 3 years earlier. Her blood pres-sure was 131/71 mm Hg. Laboratory tests confirmed nephrotic syndrome, and serum
creatinine was 2.7 mg/dl (estimated glomerular filtration rate was 18 ml/min/1.73 m2). Immu-
nologic workup revealed hypocomplementemia and type II (mixed) cryoglobulinemia. Kidney
biopsy showed cryoglobulin-associated mesangioproliferative glomerulonephritis.
Ultrasonography disclosed moderate pericardial effusion and dilated cardiomyopathy with
global hypokinesia and 29% left ventricular ejection fraction (A and B, Online Video 1). Car-
diac magnetic resonance CMR imaging showed a mildly dilated but severely hypokinetic left
ventricle (C, Online Video 2) but no late gadolinium enhancement. Coronary angiography was
normal. We considered that HCV-related cryoglobulinemia was responsible for both the glo-
merulonephritis and the cardiomyopathy (1). After treatment with rituximab, a monoclonal
anti-CD20 antibody, we observed B-cell depletion, clearing of cryoglobulin, and normalization
of all renal parameters.
Cardiac re-evaluation was performed 4 months later. Ultrasonography showed dramatic im-
provement in left ventricular ejection fraction (D and E, Online Video 3), confirmed by CMR
(F and G, Online Video 4). The HCV infection is currently treated with pegylated-interferon
and ribavirin. No recurrence of cryoglobulinemia has been detected 16 months after rituximab
therapy.
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